Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Pascal Soriot, former head of Roche’s pharmaceutical division, has been named AstraZeneca’s new CEO. He will join AstraZeneca on Oct. 1, and interim CEO Simon Lowth will return to his role as chief financial officer. Prior to starting his now 26-year career in the drug industry, Soriot, 53, was a practicing veterinarian. Meanwhile, effective Sept. 1, Daniel O’Day will lead Roche Pharma and Roland Diggelmann will succeed him as head of Roche Diagnostics.
This article has been sent to the following recipient: